These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31509900)

  • 41. Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System.
    Peyser TA; Nakamura K; Price D; Bohnett LC; Hirsch IB; Balo A
    Diabetes Technol Ther; 2015 Aug; 17(8):548-54. PubMed ID: 25961446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study.
    Zamboni WA; Wong HP; Stephenson LL; Pfeifer MA
    Undersea Hyperb Med; 1997 Sep; 24(3):175-9. PubMed ID: 9308140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retrospective Evaluation of Glycemic Control With Basal-Bolus or Neutral Protamine Hagedorn Insulin Regimens in Patients Receiving Continuous Enteral Nutrition Therapy in Medicine Wards.
    Hijaze D; Szalat A
    Nutr Clin Pract; 2017 Aug; 32(4):557-562. PubMed ID: 28760108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoglycemia Incidence and Factors Associated in a Cohort of Patients With Type 2 Diabetes Hospitalized in General Ward Treated With Basal Bolus Insulin Regimen Assessed by Continuous Glucose Monitoring.
    Gómez AM; Imitola Madero A; Henao Carrillo DC; Rondón M; Muñoz OM; Robledo MA; Rebolledo M; García Jaramillo M; León Vargas F; Umpierrez G
    J Diabetes Sci Technol; 2020 Mar; 14(2):233-239. PubMed ID: 30678495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Accuracy, utility and complications of continuous glucose monitoring system (CGMS) in pediatric patients with type 1 diabetes].
    Maia FF; Araújo LR
    J Pediatr (Rio J); 2005; 81(4):293-7. PubMed ID: 16106313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
    Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
    Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H; Höxter G
    Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials.
    DeVries JH; Bailey TS; Bhargava A; Gerety G; Gumprecht J; Heller S; Lane W; Wysham CH; Zinman B; Bak BA; Hachmann-Nielsen E; Philis-Tsimikas A
    Diabetes Obes Metab; 2019 Mar; 21(3):622-630. PubMed ID: 30362250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.
    Hsia E; Seggelke S; Gibbs J; Hawkins RM; Cohlmia E; Rasouli N; Wang C; Kam I; Draznin B
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3132-7. PubMed ID: 22685233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8.
    Harris C; Forst T; Heise T; Plum-Mörschel L; Watkins E; Zhang Q; Fan L; Garhyan P; Porksen N
    Diabetes Technol Ther; 2017 Aug; 19(8):463-470. PubMed ID: 28817342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy.
    Sola-Gazagnes A; Faucher P; Jacqueminet S; Ciangura C; Dubois-Laforgue D; Mosnier-Pudar H; Roussel R; Larger E
    Diabetes Metab; 2020 Apr; 46(2):158-163. PubMed ID: 31415813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Minimizing postprandial hypoglycemia in Type 1 diabetes patients using multiple insulin injections and capillary blood glucose self-monitoring with machine learning techniques.
    Oviedo S; Contreras I; Bertachi A; Quirós C; Giménez M; Conget I; Vehi J
    Comput Methods Programs Biomed; 2019 Sep; 178():175-180. PubMed ID: 31416546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes.
    Demma LJ; Carlson KT; Duggan EW; Morrow JG; Umpierrez G
    J Clin Anesth; 2017 Feb; 36():184-188. PubMed ID: 28183563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detemir vs Glargine: Comparison of Inpatient Glycemic Control.
    Capson J; Cade K; Avanesyan A
    J Am Osteopath Assoc; 2019 Feb; 119(2):89-95. PubMed ID: 30688354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes after pancreaticoduodenectomy with or without preoperative hyperbaric oxygen therapy.
    Jacoby H; Camporesi EM; Ross SB; Sucandy I; Bosco G; Syblis C; Crespo K; Rosemurgy A
    Undersea Hyperb Med; 2024; 51(1):7-15. PubMed ID: 38615348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of venous, capillary and interstitial blood glucose data measured during hyperbaric oxygen treatment from patients with diabetes mellitus.
    Baines C; Vicendese D; Cooper D; McGuiness W; Miller C
    Diving Hyperb Med; 2021 Sep; 51(3):240-247. PubMed ID: 34547774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glycopolymer Nanoparticles with On-Demand Glucose-Responsive Insulin Delivery and Low-Hypoglycemia Risks for Type 1 Diabetic Treatment.
    Fu Y; Sun Y; Chen M; Xing W; Xu Y; Qian X; Zhu W
    Biomacromolecules; 2022 Mar; 23(3):1251-1258. PubMed ID: 35084834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trends in Medicare Costs of Hyperbaric Oxygen Therapy, 2013 through 2022.
    Gelly HB; Fife CE; Walker D; Eckert KA
    Undersea Hyperb Med; 2024; 51(2):137-144. PubMed ID: 38985150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extended Kalman filter state estimation-based nonlinear explicit model predictive control design for blood glucose regulation of type 1 diabetic patient.
    Acharya D; Das DK
    Med Biol Eng Comput; 2022 May; 60(5):1347-1361. PubMed ID: 35274280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of hyperbaric oxygen therapy on diabetes-related oral complications.
    Altun BD; Sümen SG; Öçbe M; Dumlu A
    Undersea Hyperb Med; 2024; 51(2):101-106. PubMed ID: 38985146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.